TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer November 20, 1998
TCL Archive SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma September 29, 2006
TCL Archive Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds February 25, 2005
TCL Archive Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing October 8, 2010
TCL Archive NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors. September 22, 2006
